Missing/wrong data?
Log in to edit
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
scientific article published on 05 December 2016
Author/s
author: Jordi Bruix, Josep M. Llovet, Alessandro Granito, Yi-Hsiang Huang, Ann-Lii Cheng, Masatoshi Kudo, Gerold Meinhardt, Shukui Qin, Tianqiang Song
Work details
Publication date
December 5, 2016
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.